ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 176 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2016. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $36,000 | -96.4% | 520 | -97.4% | 0.02% | -93.8% |
| Q2 2016 | $996,000 | -76.2% | 20,379 | -69.2% | 0.26% | -67.9% |
| Q1 2016 | $4,190,000 | -29.9% | 66,189 | +24.2% | 0.80% | -4.5% |
| Q4 2015 | $5,976,000 | +54.6% | 53,272 | +32.7% | 0.84% | +63.0% |
| Q3 2015 | $3,866,000 | -25.8% | 40,142 | -21.1% | 0.51% | +2.6% |
| Q2 2015 | $5,208,000 | -41.2% | 50,874 | -64.3% | 0.50% | -36.3% |
| Q1 2015 | $8,856,000 | +255.7% | 142,634 | +151.3% | 0.79% | +252.9% |
| Q4 2014 | $2,490,000 | -60.7% | 56,749 | -49.3% | 0.22% | -62.0% |
| Q3 2014 | $6,334,000 | – | 111,920 | – | 0.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 497,899 | $31,617,000 | 3.20% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 390,453 | $24,794,000 | 1.81% |
| First Light Asset Management, LLC | 180,017 | $11,431,000 | 1.59% |
| Rock Springs Capital Management LP | 580,000 | $36,830,000 | 1.33% |
| Capital Impact Advisors, LLC | 36,165 | $2,244,000 | 0.82% |
| SECTOR GAMMA AS | 79,653 | $5,058,000 | 0.81% |
| Verity Asset Management, Inc. | 7,193 | $457,000 | 0.51% |
| Opus Point Partners Management, LLC | 5,064 | $322,000 | 0.48% |
| Capital International Sarl | 52,000 | $3,302,000 | 0.46% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 6,216 | $394,000 | 0.43% |